Jens Bukh

Jens Bukh

Professor

Member of:


    1. 2018
    2. Published

      Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: A clinical randomized study

      Sølund, C., cgl303, cgl303, Mössner, B., Laursen, A. L., Røge, B. T., Kjær, M. S., Gerstoft, Jan, Christensen, P. B., Pedersen, M. S., Schønning, Kristian, Fahnøe, Ulrik, Bukh, Jens & Weis, Nina, 2018, In: European Journal of Gastroenterology and Hepatology. 30, 10, p. 1177-1186 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies

      Humes, D., Ramirez Almeida, Santseharay, Jensen, T. B., Li, Y. P., Gottwein, Judith Margarete & Bukh, Jens, 2018, In: Virology. 522, p. 177-192 16 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a

      Mejer, N., Fahnøe, Ulrik, Galli, Andrea, Ramirez Almeida, Santseharay, Benfield, Thomas & Bukh, Jens, 2018, In: Journal of General Virology. 99, 8, p. 1066-1077 12 p., 001095.

      Research output: Contribution to journalJournal articleResearchpeer-review

    Previous 1 2 Next

    ID: 12437